Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Milurit's place in therapy.

B Gömör1, B Szebenyi

  • 1Department of Rheumatology and Physiotherapy, Postgraduate Medical School, Budapest.

Therapia Hungarica (English Edition)
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.

Annals of the rheumatic diseases·2006
Same author

A comparison of the semiflexed (MTP) view with the standing extended view (SEV) in the radiographic assessment of knee osteoarthritis in a busy routine X-ray department.

Rheumatology (Oxford, England)·2004
Same author

[National Institute of Rheumatology and Physiotherapy--established 50 years ago].

Orvosi hetilap·2002
Same author

Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis.

Osteoarthritis and cartilage·2001
Same author

[Hypophosphatemic oncogenic osteomalacia].

Orvosi hetilap·2001
Same author

Repeated cyclosporine therapy of peripheral arthritis associated with ankylosing spondylitis.

Medical science monitor : international medical journal of experimental and clinical research·2001

Allopurinol (Milurit) effectively treats hyperuricemia but requires careful patient selection to prevent severe side effects like hypersensitivity syndrome. Proper drug choice improves outcomes and minimizes risks.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Drug Safety

Background:

  • Hyperuricemia is associated with various clinical conditions.
  • Allopurinol is a common therapeutic agent for managing elevated uric acid levels.
  • Understanding allopurinol's profile is crucial for safe and effective use.

Purpose of the Study:

  • To provide a comprehensive review of allopurinol (Milurit).
  • To discuss its mechanism of action, drug interactions, and side effects.
  • To outline indications, contraindications, and dosage for adults and children.

Main Methods:

  • Review of historical allopurinol therapy.
  • Discussion of pharmacological properties and clinical applications.
  • Analysis of safety data, including hypersensitivity syndrome.

Related Experiment Videos

Main Results:

  • Allopurinol is an effective treatment for hyperuricemia.
  • It is not the only treatment option available.
  • Careful drug selection is vital for therapeutic success and side effect prevention.

Conclusions:

  • Allopurinol (Milurit) offers significant benefits in managing hyperuricemia.
  • Preventing severe side effects, such as allopurinol hypersensitivity syndrome, is paramount.
  • Optimizing drug choice enhances treatment efficacy and patient safety.